Country: Olanda
Lingwa: Ingliż
Sors: HMA (Heads of Medicines Agencies)
carprofen 50 mg
Norbrook Laboratories Limited
QM01AE91
Solution for injection
carprofen
Cats, Dogs
2008-10-29
Revised: November 2012 AN: 00800/2012 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Reproval 50mg/ml Solution for Injection for Dogs and Cats (RMS) Norocarp 50mg/ml Solution for Injection for Dogs and Cats (all CMS except France, Germany, Sweden and Denmark) Carprieve 50mg/ml Solution for Injection for Dogs and Cats (France and Germany) Norocarp vet. 50mg/ml Solution for Injection for Dogs and Cats (Sweden) Norodyl vet. 50mg/ml Solution for Injection for Dogs and Cats (Denmark) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Carprofen 50mg Excipients: Benzyl Alcohol 10mg Sodium Formaldehyde Sulphoxylate 2.5mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection A clear colourless to pale yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES DOGS: For the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery. CATS: For the control of post operative pain following ovariohysterectomy and soft tissue surgery. Revised: November 2012 AN: 00800/2012 Page 2 of 6 4.3 CONTRAINDICATIONS Do not use in animals suffering from cardiac, hepatic or renal disease or gastrointestinal problems, where there is a possibility of gastrointestinal ulceration or bleeding, or hypersensitivity to carprofen or any other NSAIDs or any Aqra d-dokument sħiħ